Christopher Wragg

1.8k total citations
17 papers, 361 citations indexed

About

Christopher Wragg is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Wragg has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Wragg's work include Glioma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (6 papers) and Brain Metastases and Treatment (3 papers). Christopher Wragg is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (6 papers) and Brain Metastases and Treatment (3 papers). Christopher Wragg collaborates with scholars based in United Kingdom, Germany and United States. Christopher Wragg's co-authors include Claire Faulkner, Kathreena M. Kurian, Paul White, Harry R. Haynes, Sebastian Brandner, Sarah Jefferies, Julian P. T. Higgins, Alexandra McAleenan, Sarah Dawson and Lena Schmidt and has published in prestigious journals such as Blood, Cochrane Database of Systematic Reviews and Physical Chemistry Chemical Physics.

In The Last Decade

Christopher Wragg

15 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Wragg United Kingdom 10 162 124 74 74 64 17 361
C. Grace United Kingdom 7 121 0.7× 130 1.0× 50 0.7× 160 2.2× 45 0.7× 11 352
Shigetoshi Kobayashi Japan 10 105 0.6× 138 1.1× 81 1.1× 106 1.4× 33 0.5× 30 476
Jane Chalker United Kingdom 8 66 0.4× 153 1.2× 50 0.7× 41 0.6× 53 0.8× 12 382
Carmen Azqueta Spain 12 108 0.7× 120 1.0× 36 0.5× 156 2.1× 43 0.7× 27 370
Paulo N. G. Pereira Belgium 9 105 0.6× 322 2.6× 40 0.5× 18 0.2× 37 0.6× 10 481
Ester Rosenthal Israel 9 69 0.4× 97 0.8× 38 0.5× 128 1.7× 34 0.5× 13 324
Patrick A. Lennon United States 14 293 1.8× 255 2.1× 91 1.2× 188 2.5× 77 1.2× 32 802
Lucrezia della Volpe Italy 5 113 0.7× 266 2.1× 24 0.3× 43 0.6× 29 0.5× 10 468
Caterina Tatarelli Italy 8 103 0.6× 209 1.7× 19 0.3× 136 1.8× 40 0.6× 20 478
Benoît Quilichini France 11 122 0.8× 78 0.6× 18 0.2× 31 0.4× 53 0.8× 22 242

Countries citing papers authored by Christopher Wragg

Since Specialization
Citations

This map shows the geographic impact of Christopher Wragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wragg more than expected).

Fields of papers citing papers by Christopher Wragg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Wragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wragg. The network helps show where Christopher Wragg may publish in the future.

Co-authorship network of co-authors of Christopher Wragg

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Wragg. A scholar is included among the top collaborators of Christopher Wragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Wragg. Christopher Wragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lynch, Garrett R., Steven Walker, J Symonds, et al.. (2025). S35 Reducing repeat pleural biopsies in suspected mesothelioma (REPLICA). A30.2–A31.
2.
3.
4.
McAleenan, Alexandra, Hayley E Jones, Ashleigh Kernohan, et al.. (2022). Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma. Cochrane Database of Systematic Reviews. 2022(3). CD013387–CD013387. 15 indexed citations
5.
Brandner, Sebastian, Alexandra McAleenan, Hayley E Jones, et al.. (2021). Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review. Neuropathology and Applied Neurobiology. 48(4). e12790–e12790. 18 indexed citations
6.
Brandner, Sebastian, Alexandra McAleenan, Claire Kelly, et al.. (2021). MGMTpromoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-Oncology. 23(9). 1457–1469. 39 indexed citations
7.
McAleenan, Alexandra, Claire Kelly, Francesca Spiga, et al.. (2021). Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Database of Systematic Reviews. 2021(3). CD013316–CD013316. 25 indexed citations
8.
Lavrentiev, M. Yu., Neil L. Allan, & Christopher Wragg. (2019). Lithium oxide: a quantum-corrected and classical Monte Carlo study. Physical Chemistry Chemical Physics. 21(27). 14964–14972. 4 indexed citations
9.
McAleenan, Alexandra, Hayley E Jones, Ashleigh Kernohan, et al.. (2019). Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma. Cochrane Database of Systematic Reviews. 10 indexed citations
10.
McAleenan, Alexandra, Amy Howell, Ashleigh Kernohan, et al.. (2019). Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Database of Systematic Reviews. 1 indexed citations
11.
Ellis, Hayley, Caitríona E. McInerney, Daniel Schrimpf, et al.. (2019). Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches. Journal of Oncology. 2019. 1–14. 5 indexed citations
12.
Ellis, Hayley, Felix Sahm, Daniel Schrimpf, et al.. (2018). Mutational landscape of primary and recurrent glioblastoma reveals potentially actionable SNVs including WNT pathway variation. Neuro-Oncology. 20(suppl_1). i16–i16. 1 indexed citations
13.
Schwab, Claire, Sarra Ryan, Lucy Chilton, et al.. (2016). EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications. Blood. 127(18). 2214–2218. 80 indexed citations
14.
Faulkner, Claire, Hayley Ellis, Abigail Shaw, et al.. (2015). BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum. Journal of Neuropathology & Experimental Neurology. 74(9). 867–872. 43 indexed citations
15.
Schwab, Claire, Rebecca Andrews, Lucy Chilton, et al.. (2014). EBF1-PDGFRΒ Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications. Blood. 124(21). 1068–1068. 2 indexed citations
16.
Faulkner, Claire, Hannah Williams, Christopher Wragg, et al.. (2014). EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers. British Journal of Neurosurgery. 29(1). 23–29. 60 indexed citations
17.
Allen, Hana Lango, Richard Caswell, Weijia Xie, et al.. (2014). Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans. Journal of Medical Genetics. 51(4). 264–267. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Grace Breakdown of academic impact, for papers by Shigetoshi Kobayashi Breakdown of academic impact, for papers by Jane Chalker Breakdown of academic impact, for papers by Carmen Azqueta Breakdown of academic impact, for papers by Paulo N. G. Pereira Breakdown of academic impact, for papers by Ester Rosenthal Breakdown of academic impact, for papers by Patrick A. Lennon Breakdown of academic impact, for papers by Lucrezia della Volpe Breakdown of academic impact, for papers by Caterina Tatarelli Breakdown of academic impact, for papers by Benoît Quilichini
Rankless by CCL
2026